CXCL1 and Alzheimer disease: Tau cleavage, which is considered an early event in AD development, was also observed after intrahippocampal microinjection of lentiviral CXCL1 in aged (15–18 months of age), but not in adult (5–10 months of age) mice (Zhang et al. 2015).